Merck (LIM:MRK) Short Interest


LIM:MRK Merck & Co Inc LIM:MRK
71 GF Score
Price $120.00
GF Value $113.28
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Merck Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LIM:MRK vs ABBV, AMGN, GILD: Short Interest Comparison

For the Drug Manufacturers - General subindustry, Merck's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Short Interest distribution charts can be found below:

* The bar in red indicates where Merck's Short Interest falls into.


LIM:MRK
71GF Score
Merck & Co Inc LIM:MRK
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (LIM:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of $120.00 is trading 5.9% above its estimated GF Value™ of $113.28. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for LIM:MRK:

  • Short Interest:
  • GF Value™: $113.28 vs. price of $120.00 (5.9% above fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the LIM:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
71GF Score

Get the complete analysis for LIM:MRK

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$120.00
Price
$113.28
GF Value